Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

591 public trials 87 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

NCT01672853

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +9 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Southern California Liver Center Chula Vista, California, United States
  • Southern California Liver Centers Coronado, California, United States
View all 75 locations
View Trial Details
Completed

The Patient-Reported Outcomes Project of HCV-TARGET

NCT02601820

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • University of California at Davis Davis, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Gainesville, Florida, United States
  • Rush University Chicago, Illinois, United States
View Trial Details
Completed

The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

NCT01842581

Conditions
Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +12 more
Locations
  • Banner Research Phoenix, Arizona, United States
  • Southern California Liver Centers Coronado, California, United States
  • UCSF/Fresno - CRMC Fresno, California, United States
  • UCSD Clinical & Translational Research Institute La Jolla, California, United States
View all 43 locations
View Trial Details
Completed

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

NCT02686762

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona Clinical and Translational Sciences Research Center Tucson, Arizona, United States
  • Preferred Research Partners, Inc. Little Rock, Arkansas, United States
  • Fresno Clinical Research Center Freestone, California, United States
View all 103 locations
View Trial Details

Related conditions